Isotope shortage in Europe may continue until February

10/14/2008 | Diagnostic Imaging

Nuclear imaging centers in Europe likely will have another four months of molybdenum-99 shortages as the Nuclear Research and Consultancy Group announced that the High Flux Reactor in the Netherlands will remain closed until Feb. 16, 2009. Mo-99 is the parent radioisotope of the radionuclide technetium-99m, used in a majority of nuclear imaging procedures. However, the BR-2 reactor in Belgium is set to restart this week and suppliers say this could provide some relief.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC